- Home
- Browse
- National Institutes of Health
- RFA-DC-26-001
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
- Deadline
- 2027-06-17
- 287 days left
- Award ceiling
- —
- Awards
- —
- Posted
- 2026-02-05
Summary
Background Much research is devoted to developing evidence-based innovations (EBIs) that improve a person’s health and quality of life. To impact people’s lives, EBIs need to be adopted in clinical practice and everyday life. […]
The rest of this announcement — free with an account
- →The full announcement text, not the first two sentences
- →All 3 review criteria reviewers score this against, extracted from this announcement
- →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- →What similar funded projects received, from 219,000 past awards
No card required. Browsing and your first match are free.
More from National Institutes of Health
See all →NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.
3 review criteria on fileNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileAlso in climate-environment
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileCellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function.
3 review criteria on fileSocial disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage research that addresses the link between social disconnection in late-life and late-life suicidal thoughts and behaviors.
3 review criteria on fileOfficial announcement: https://www.grants.gov/search-results-detail/359274Source: nih_guide+grants_gov. Always confirm dates with the funder.